Strategy
Exclusively Healthcare.
We Are Disciplined, Thesis-Driven Investors.
Sheridan invests exclusively within the healthcare industry.
We believe our sector research and expertise allows us to proactively identify compelling trends and attractive companies within the healthcare landscape, move with speed and certainty to close a transaction, and accelerate value creation post close. We strive to be collaborative and friendly and drive extraordinary business growth.
Services &
Products
Software &
Technology
Investment Criteria
Healthcare
Outsourced Services
- Pharma Services
- Payor Services
- Tech-Enabled
- HC or Life Sciences Consulting
- Medical Education and Training
Healthcare
Outsourced Services
- Pharma Services
- Payor Services
- Tech-Enabled
- HC or Life Sciences Consulting
- Medical Education and Training
Healthcare
Providers
- Behavioral Health
- Dental Specialties
- ENT
- Women’s Health
- Specialty Veterinary Services
- Post-Acute
Healthcare
Providers
- Behavioral Health
- Dental Specialties
- ENT
- Women’s Health
- Specialty Veterinary Services
- Post-Acute
Medical
Products
- Contract Manufacturing
- Specialty Pharmacy & Compounding
- Medical Products
- Consumables
- Specialty Packaging
Medical
Products
- Contract Manufacturing
- Specialty Pharmacy & Compounding
- Medical Products
- Consumables
- Specialty Packaging
Target Company Characteristics
- Headquartered in the United States or Canada
- Founder-owned, entrepreneurially-led
- Strong business model, with a history of consistent growth and profitability
- Positive secular growth trends and resilient end market
- Fragmented market landscape
- Strong demand, implying good revenue visibility (recurring or re-occurring)
- Limited regulatory risk
Transaction Types
- Control positions in healthcare software and technology businesses
- Partial recapitalizations or buyouts
Transaction Size
- Target platform EBITDA
$5 – $25M - Target equity investments
$30 – $150M - Target add-on investments
+ Cash Flow Positive
Investment Criteria
Provider
Solutions
Provider
Solutions
Payor
Solutions
Payor
Solutions
Pharma
Solutions
Pharma
Solutions
Patient-Facing
Solutions
Patient-Facing
Solutions
Target Company Characteristics
- Headquartered in the United States or Canada
- Founder-owned, entrepreneurially-led
- Strong business model, with a history of consistent growth and profitability
- Positive secular growth trends and resilient end market
- Fragmented market landscape
- Strong demand, implying good revenue visibility (recurring or re-occurring)
- Limited regulatory risk
Transaction Types
- Control positions in healthcare businesses
- Partial recapitalizations or buyouts
Transaction Size
- Target platform EBITDA
$0 – 10M - Target platform revenue
$5 – 30M - Target equity investments
$15 – 150M
Target company characteristics are for illustrative purposes only and is subject to change. There is no guarantee that Sheridan will achieve its objectives.
Helping Build Exceptional Companies